BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

HemoGenix Inc. 

4405 N. Chestnut Street
Suite D
Colorado Springs  Colorado  80907  U.S.A.
Phone: 719-264-6250 Fax: 719-264-6253


SEARCH JOBS


Industry
Biotechnology






 Company News
HemoGenix Inc. Announces Publication of its White Paper on "Stem Cells and Predictive in Vitro Toxicity Testing" 11/18/2011 9:45:57 AM    More...
Vitro Diagnostics (VODG) Launches New Stem Cell Products for Clinical Use & Presents Webinar with HemoGenix Inc. 7/20/2011 8:30:22 AM    More...
Vitro Diagnostics (VODG) Expands HemoGenix Inc. Alliance to Include Cell-based Testing for Liver Toxicity 10/19/2010 10:04:00 AM    More...
Vitro Diagnostics (VODG) and HemoGenix Inc. Launch New Products at an International Stem Cell Meeting 6/15/2010 10:15:26 AM    More...
Vitro Diagnostics (VODG) Forms Strategic Alliance With a Leading Stem Cell Company HemoGenix Inc. 4/28/2010 11:07:13 AM    More...
HemoGenix Inc. Receives Issued Patent for its HALO(R) Technology Platform 4/9/2008 10:48:22 AM    More...
ImmuneRegen BioSciences, Inc. (IRBO) Announces Material Transfer Agreement with HemoGenix Inc. 1/28/2008 9:25:53 AM    More...
HemoGenix Inc. Introduces HALO(R)-96 PQR, the First Stem Cell Potency and Release Assay to Incorporate a Reference Standard 12/5/2007 12:56:09 PM    More...
HemoGenix LLC Launches HALO(TM) 384HT, The First Ever High Throughput Predictive Stem Cell Hemotoxicity Screening Platform 6/22/2006 1:41:11 PM    More...
Platform For Drug Development Screening Will Be Unveiled By HemoGenix LLC At The 44th Annual Meeting Of The Society Of Toxicology In New Orleans, March 6-10, 2004 10/19/2005 5:12:55 PM    More...
12

//-->